-
Biotech
International Isotopes Inc. (OTCBB:INIS) is Attracting Smart Money
[ad_1] In a simply printed Form 13, filed with the US Securities and Exchange Commission (SEC), International Isotopes Inc. (OTCBB:INIS) reported…
Read More » -
Cannabis
TerrAscend Enters US Hemp-Derived Products Market
[ad_1] Toronto, ON — December 24, 2018 — /D.M.O. Newswire/ — TerrAscend Corp. (CSE: TER; OTCQX: TRSSF) (“TerrAscend”) at the moment introduced…
Read More » -
News
Look for S&P 500 to bottom between 2,250 and 2,335
[ad_1] I do know of no different evaluation methodology that gives higher context to understanding the market than Elliott Wave…
Read More » -
News
VT: Trend-Following Beat Buy-And-Hold In 2018
[ad_1] Investment Thesis When it involves portfolio technique, as traders we are sometimes our personal worst enemies. Equity traders have…
Read More » -
News
India stocks lower at close of trade; Nifty 50 down 0.84% By Investing.com
[ad_1] India stocks lower at close of commerce; Nifty 50 down 0.84% Investing.com – India stocks had been lower after…
Read More » -
Biotech
Communique from EGM in Oncology Venture A/S Stockholm Stock Exchange:OV
[ad_1] Company Announcement Communique from EGM in Oncology Venture A/S Hoersholm, Denmark, December 18, 2018 – at this time,…
Read More » -
Cannabis
Cannabis Education for Healthcare Professionals
[ad_1] Industry and commerce teams present training on medical hashish for healthcare professionals. Medical hashish has gained lots of floor…
Read More » -
News
January 7, 2019 Could Sea Change GSE Investors – Fannie Mae (OTCMKTS:FNMA)
[ad_1] The final Federal Housing Finance Agency appearing director, Edward Demarco, instituted the Third Amendment internet value sweep. Since Trump…
Read More » -
News
Asian markets a reluctant spectator to U.S. political theater By Reuters
[ad_1] © Reuters. Pedestrians are mirrored in a window in entrance of a board displaying stock costs on the Australian…
Read More » -
Biotech
Chugai preps filings for IL-6 drug in rare disease, chasing Soliris
[ad_1] Chugai has the optimistic part 3 knowledge it must file IL-6-targeting antibody satralizumab for approval in neuromyelitis optica spectrum…
Read More »
